COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
== Meet The Team ==
== Meet The Team ==
; {{AE}}
; {{AE}}
* Cardiovascular Disorders and COVID-19 Team Members
* Dermatologic Disorders of COVID-19 Team Members
* Nephrologic Disorders and COVID-19 Team Members
* Neurologic Disorders and COVID-19 Team Members
* Ongoing Clinical Trials of COVID-19 Team Members
* Pulmonary Disorders and COVID-19 Team Members
* Radiologic Manifestations of COVID-19 Team Members
* Hematologic disorders and COVID-19 Team Members


*[[User:Aisha Adigun|Aisha Adigun, M.D.]]
*[[User:Aisha Adigun|Aisha Adigun, M.D.]]
Line 24: Line 15:
*[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]
*[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]
*Mandana Safakhah
*Mandana Safakhah
*[[User:Mitra Chitsazan|Mitra Chitsazan]]
*Mitra Chitsazan
*Mounika Vadiyala
*Mounika Vadiyala
*Muhammad Adnan Haider
*Muhammad Adnan Haider
Line 37: Line 28:
*[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
*[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
*Sara Haddadi
*Sara Haddadi
*[[User:Sara Mohsin|Sara Mohsin, M.D.]]
*Sara Mohsin
*Sara Zand
*Sara Zand
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]

Revision as of 17:05, 10 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief: